相关实验视频
Updated: Jun 11, 2025

08:46
An Improved Method for Rapid Intubation of the Trachea in Mice
Published on: February 22, 2016
25.2K
作为Rocuronium的辅助剂,改善输管条件并缩短输管时间:一项随机对照研究
Franklin J Roy1, Swetha Ramani1, Karthika Urkavalan1
1Anaesthesiology, SRM Medical College Hospital and Research Centre, Chennai, IND.
Cureus
|October 7, 2024
概括
硫酸盐预处理与罗库初始化相结合,显著加快了罗库的速度.
科学领域:
- 麻醉学和药理学 麻醉学和药理学
背景情况:
- 神经肌肉阻塞对于内内管管道输入至关重要.
- 罗库原始化用于加速神经肌肉阻塞的发生.
- 硫酸在增强神经肌肉阻塞方面的潜在作用正在调查中.
研究的目的:
- 为了比较罗库原始化与硫酸盐预处理和罗库原始化技术的组合.
- 确定硫酸预处理是否可以进一步加快输管过程中神经肌肉阻塞的发生.
主要方法:
- 一个双盲随机对照试验,涉及150名患者.
- 三组:预处理和罗库原始化 (MP),单独罗库原始化 (P) 和控制 (C).
- 评估了神经肌肉监测和输管分级.
主要成果:
- 与P组和C组相比,MP组的作用开始 (58.90秒) 和持续时间 (54.92分钟) 显著更快,与P组和C组相比.
- 组MP还显示了明显更好的输管条件 (33名患者) 比组P (23) 和组C (16).
结论:
- 硫酸预处理与罗库初始化相结合,显著加快了罗库的出现,并延长了它的持续时间.
- 这种结合技术可以改善输管条件,没有任何不良影响.
- 这些发现支持使用硫酸预处理来增强罗库的疗效.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
475
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
475
Skeletal Muscle Relaxants: Adverse Effects
345
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
345
Depolarizing Blockers: Mechanism of Action
1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
Depolarizing Blockers: Pharmocokinetics
315
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
315
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
401
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
401
Cholinergic Antagonists: Therapeutic Uses
729
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
729

